Praxis Precision Medicines, Inc. is a clinical-stage biopharmaceutical company headquartered in Cambridge, Massachusetts, dedicated to developing innovative therapies for central nervous system disorders linked to neuronal imbalance. Utilizing a proprietary scientific platform, Praxis aims to identify and advance novel treatments for a range of neurological conditions, prioritizing those with significant unmet medical needs. With a strong pipeline and a commitment to enhancing patient outcomes and quality of life, the company is well-positioned to make a meaningful impact in the biopharmaceutical sector.
Click "Analyze" to generate stock analysis
PRAX Price Trend and Signals
PRAX Option Volumes & Open Interests (aggregated)
PRAX Put Call Ratios and IV (aggregated)
PRAX Financials
2025-10-28Somewhat Bullishprice_signal
Yearly high detected.
2025-10-21Somewhat Bullishprice_signal
Yearly high detected.
2025-10-17Somewhat Bullishprice_signal
Yearly high detected.
2025-10-17Bullishprice_signal
Large price change detected: 16.77%.
2025-10-16Neutralvolume_signal
Abnormal volume detected compared to 5-day moving average.
2025-10-16Neutralvolume_signal
Abnormal volume detected compared to 10-day moving average.
2025-10-16Neutralvolume_signal
Abnormal volume detected compared to 20-day moving average.
2025-10-16Neutralvolume_signal
Abnormal volume detected compared to 3 mon moving average.
2025-10-16Somewhat Bullishprice_signal
Yearly high detected.
2025-10-16Bullishprice_signal
Large price change detected: 183.71%.
2025-10-16Neutraloption_volume_signal
Abnormal option volume detected compared to 5-day moving average.
2025-10-16Neutraloption_volume_signal
Abnormal option volume detected compared to 10-day moving average.
2025-10-16Neutraloption_volume_signal
Abnormal option volume detected compared to 20-day moving average.
2025-10-16Neutraloption_volume_signal
Abnormal option volume detected compared to 3 mon moving average.